Neximmune Inc Stock - NEXI Share Price Today, News and Discussion

NexImmune, Inc. engages in the development of novel approach to immunotheraphy designed to create therapies with curative potential for patients with cancer and other life threatening immune-mediated diseases. Its product candidates are NEXI-001 in acute myeloid leukemia, or AML, and NEXI-002 in multiple myeloma, or MM. The company was founded by Kenneth C. Carter, Jonathan Schneck, and Mathias Oelke in June 7, 2011 and is headquartered in Gaithersburg, MD.

Sector:

Health Technology

Industry:

Pharmaceuticals Major

Employees:

74

Current Price	$0.4198
Prev Close	$0.4141
Open	$0.44
Dividend Yield	0.00%
50-Day Moving Average	$0.3566
Beta	1.33
Avg. Volume	283,088.55
PE Ratio	N/A

52-Week High	$4.91
52-Week Low	$0.1947
Market Capitalization	$10.8M
EPS	-$2.63
Price to Book	0.23
Revenue Per Employee	N/A
Enterprise Value/EBITDA	0.52

No NEXI news at the moment.

NEXI Neximmune Inc

About

Feed

Fundamentals

News